全文获取类型
收费全文 | 210132篇 |
免费 | 28527篇 |
国内免费 | 7568篇 |
专业分类
耳鼻咽喉 | 1705篇 |
儿科学 | 1564篇 |
妇产科学 | 5162篇 |
基础医学 | 15262篇 |
口腔科学 | 2162篇 |
临床医学 | 16889篇 |
内科学 | 20348篇 |
皮肤病学 | 1362篇 |
神经病学 | 810篇 |
特种医学 | 6093篇 |
外国民族医学 | 258篇 |
外科学 | 29148篇 |
综合类 | 27769篇 |
现状与发展 | 38篇 |
一般理论 | 3篇 |
预防医学 | 10194篇 |
眼科学 | 113篇 |
药学 | 14643篇 |
144篇 | |
中国医学 | 5857篇 |
肿瘤学 | 86703篇 |
出版年
2024年 | 723篇 |
2023年 | 4497篇 |
2022年 | 8797篇 |
2021年 | 11454篇 |
2020年 | 10688篇 |
2019年 | 9568篇 |
2018年 | 9161篇 |
2017年 | 9638篇 |
2016年 | 10361篇 |
2015年 | 12025篇 |
2014年 | 17239篇 |
2013年 | 16973篇 |
2012年 | 13721篇 |
2011年 | 13943篇 |
2010年 | 10096篇 |
2009年 | 10261篇 |
2008年 | 10548篇 |
2007年 | 9896篇 |
2006年 | 8747篇 |
2005年 | 7207篇 |
2004年 | 5971篇 |
2003年 | 4990篇 |
2002年 | 4203篇 |
2001年 | 3918篇 |
2000年 | 3256篇 |
1999年 | 2764篇 |
1998年 | 2338篇 |
1997年 | 2036篇 |
1996年 | 1642篇 |
1995年 | 1529篇 |
1994年 | 1261篇 |
1993年 | 987篇 |
1992年 | 865篇 |
1991年 | 774篇 |
1990年 | 600篇 |
1989年 | 548篇 |
1988年 | 444篇 |
1987年 | 394篇 |
1986年 | 302篇 |
1985年 | 375篇 |
1984年 | 318篇 |
1983年 | 205篇 |
1982年 | 212篇 |
1981年 | 192篇 |
1980年 | 172篇 |
1979年 | 118篇 |
1978年 | 78篇 |
1977年 | 70篇 |
1976年 | 55篇 |
1975年 | 36篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
151.
因症就诊检出早期大肠癌的临床及病理学特征 总被引:1,自引:0,他引:1
目的探讨在就诊的肛肠病人中如何提高早期大肠癌的检出率。方法在11家医院推广对肛肠病人的四项检查程序——直肠指检,乙结镜检查,大便隐血试验,和X线气钡灌肠造影。结果在4821例有肛肠症状的病人中,检出大肠癌188例,检出率为3.9%,其中180例有术后病理诊断。47/180例(26.1%)属早期癌(DukesstageA)。41/47例由上述四项检查作出初步诊断。初发症状为:(1)便血(26例,持续15.2±9.4周后就诊,肿瘤平均直径2.58cm);(2)大便习惯改变(9例,33.4±19.7周,3.39cm);(3)腹痛腹块(10例,19.2±11.2周,5.0cm);(4)贫血(2例,17.2±9.9周,4.75cm)。8/12例的A0和A1期病例属便血组,并多位于直肠。41/47例以高、中分化腺癌为主,其中15例伴有腺瘤癌变。术前曾作活检的27例中,12例未检出癌变细胞。结论四项检查对检出早期大肠癌是有效的,便血是提示早期癌最有价值的症状,加强大肠癌防治宣教,采用瘤灶多点或全瘤活检技术,高度重视大肠腺瘤和不典型增生等癌前病变,将有助于提高早期大肠癌的检出率 相似文献
152.
153.
采用放射免疫方法测定了31例大肠癌、13例非肿瘤者血清标本和20例大肠癌组织、邻近肿瘤(〈3cm)及远离肿瘤(5cm)之结肠粘膜组织匀浆标本中的胃泌素浓度。发现:Dukes C.D期大肠癌病人血清胃泌素显著高于非肿瘤者(P〈0.05);血清胃泌素浓度与病程进展呈显著正相关(P〈0.05);直肠癌病人血清胃泌素显著高于非肿瘤(P〈0.05);血清胃泌素水平与肿瘤分化程度无关;肿瘤切除后血清胃泌素显著 相似文献
154.
Mary Steidl Matsui Isabella Illarda Nianci Wang Vincent A. DeLeo 《Experimental dermatology》1993,2(6):247-256
Abstract Several lines of evidence implicate protein kinase C (PKC) in the development of basal cell and squamous cell carcinomas, tumors which originate from epidermal keratinocytes. To examine PKC in a model relevant to human skin, we exposed normal human epidermal keratinocytes (NHEK) in serum-free media to a variety of PKC agonists and antagonists. NHEK PKC activity increased up to 10-fold within the 1st hour of exposure to tetradecanoyl phorbol acetate (TPA), and gradually returned to control values within 72 h. TPA-induced PKC activity was enhanced by pretreatment of cultures with protein and RNA synthesis inhibitors. TPA-induced growth arrest and differentiation was antagonized by staurosporine. Down-regulation by bryostatin pretreatment blocked TPA-stimulated differentiation. Our overall conclusion is that activation of PKC in cultured human keratinocytes is required for differentiation. These results are crucial to the analysis of compounds suspected of promoting or inhibiting epidermal tumors. 相似文献
155.
Streptococcus sanguis, usually considered a nonpathogen of the oral cavity, was isolated from blood cultures from a patient who was subsequently found to have a cecal adenocarcinoma. Further studies are needed to determine if Streptococcus sanguis infections have diagnostic implications similar to those of Streptococcus bovis. © 1995 Wiley-Liss, Inc. 相似文献
156.
Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens 总被引:7,自引:0,他引:7
Bone mineral density (BMD) and bone mineral content (BMC) were measured in the femoral neck area, trochanteric area and Wards triangle, and in the distal radius of the left forearm before and after 1 year of endocrine treatment in 27 patients with prostatic cancer. Eleven of the patients were treated with orchidectomy and 16 with combined oral and intramuscular estrogens. The patients were free from metastases during the entire observation period. In the orchidectomized patients, BMD and BMC of the distal radius decreased significantly following treatment, whereas no changes were observed in the estrogen-treated patients. These preliminary results demonstrate that estrogens may protect bone in male subjects also and may merit further investigations on larger groups of patients. 相似文献
157.
肝门胆管癌近年有增多趋势,本文报告我院1975年~1985年间肝门胆管癌60例,占全部肝外胆管癌82例之73.1%,占同期全部胆道手术3626例之1.65%。临床表现主要有三型:1)阻塞性黄疸29例,其中25例曾误诊为肝炎;2)急性胆管炎12例;3)长期胆道疾病14例,其他5例。本组行B超检查19例,ERCP10例,PTC39例。最后诊断根据PTC和/或ERCP,剖腹术及病理检查结果。 56例施行了手术治疗,仅6例施行肿瘤连同半肝切除,姑息性肝胆管内引流15例,外引流23例,其他方法12例。平均存活时间:6例切除组24.5月,48例姑息手术组8.7月,未手术的4例为5月。文中强调早期诊断,凡40岁以上出现阻塞性黄疸或“传染性肝炎”均须警惕胆管癌,进行B超,CT,ERCP或PTC检查,文中强调PTC是诊断本病重要手段,可选择进行右左肝管PTC。本病应争取手术切除,不能切除者行肝胆管内引流或外引流,二者疗效无明显差别。 相似文献
158.
Jin S. Lee Herman I. Libshitz William K. Murphy Diane Jeffries Waun K. Hong 《Investigational new drugs》1990,8(3):299-304
Summary Thirty-one patients with stage IIIB or IV non-small cell lung cancer (NSCLC) were treated with intravenous 10-EdAM on a weekly basis. The starting dose was 80 mg/m2, with subsequent doses adjusted depending on evidence of toxicity. There were 20 men and 11 women with a median age of 58 years (range, 33–75). Response was evaluated in 30 patients, 5 with evaluable but not measurable tumors and 25 with measurable indicator lesions. There were no complete remissions; 3 patients achieved partial remission. Nine patients had a minor response, 6 showed no change, and 12 had progressive disease. Median survival for all 31 patients was 43 weeks (range, 12–65+). During the first 3-week period, the 10-EdAM dose was reduced or withheld in 19 patients (because of stomatitis in 12, SGPT elevation in 3, skin rash in 2, and granulocytopenia in 2), escalated in 11 patients, and unchanged in 1 patient. A mean of 34–88 mg/m2of 10-EdAM (median, 50) was given per week during the first 5-week period. Myelotoxicity was infrequent and there was no significant nephrotoxicity. Considering the modest side effects of this treatment and the conservative dose-modification schedule which mandated substantial dose reductions, we conclude that 10-EdAM is a promising antitumor agent for NSCLC. 相似文献
159.
160.
我院1989年至1994年共行子宫颈癌广泛切除术和盆腔淋巴结清扫术39例,其中28例行术前放射治疗,19例临床诊断为Ⅱb,随着手术技术的提高和术前放射治疗的配合,子宫颈癌的手术适应症的选择,可以扩大至Ⅱb,不增加手术的并发症,并具有一定的优点。 相似文献